Camp4 Therapeutics Corporation
CAMP
$2.30
$0.209.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.71M | -51.73M | -51.44M | -49.65M | -49.44M |
| Total Depreciation and Amortization | 1.69M | 1.70M | 1.72M | 1.73M | 1.71M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.05M | 5.89M | 5.69M | 4.76M | 4.75M |
| Change in Net Operating Assets | -3.58M | -274.00K | -883.00K | 1.39M | 589.50K |
| Cash from Operations | -47.56M | -44.41M | -44.91M | -41.77M | -42.39M |
| Capital Expenditure | -631.00K | -367.00K | -347.00K | -554.00K | -579.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -631.00K | -367.00K | -347.00K | -554.00K | -579.00K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 353.00K |
| Total Debt Repaid | -771.00K | -824.00K | -849.00K | -848.00K | -719.00K |
| Issuance of Common Stock | 76.47M | 76.47M | 207.00K | 177.00K | 181.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.68M | -3.68M | -516.00K | -304.00K | -- |
| Cash from Financing | 72.02M | 71.97M | -1.16M | -975.00K | -184.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.83M | 27.19M | -46.41M | -43.30M | -43.15M |